277 related articles for article (PubMed ID: 11169021)
21. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
[TBL] [Abstract][Full Text] [Related]
22. Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population.
Devlin AM; Clarke R; Birks J; Evans JG; Halsted CH
Am J Clin Nutr; 2006 Mar; 83(3):708-13. PubMed ID: 16522921
[TBL] [Abstract][Full Text] [Related]
23. Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis.
Anwar W; Guéant JL; Abdelmouttaleb I; Adjalla C; Gérard P; Lemoel G; Erraess N; Moutabarrek A; Namour F
Clin Chem Lab Med; 2001 Aug; 39(8):747-52. PubMed ID: 11592445
[TBL] [Abstract][Full Text] [Related]
24. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
[TBL] [Abstract][Full Text] [Related]
25. An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease.
Wrone EM; Zehnder JL; Hornberger JM; McCann LM; Coplon NS; Fortmann SP
Kidney Int; 2001 Sep; 60(3):1106-13. PubMed ID: 11532106
[TBL] [Abstract][Full Text] [Related]
26. Common polymorphisms in methylenetetrahydrofolate reductase (MTHFR): relationships with plasma homocysteine concentrations and cognitive status in elderly northern italian subjects.
Ravaglia G; Forti P; Maioli F; Scali RC; Arnone G; Talerico T; Pantieri T; Nativio V; Mantovani V; Bianchin M
Arch Gerontol Geriatr Suppl; 2004; (9):339-48. PubMed ID: 15207432
[TBL] [Abstract][Full Text] [Related]
27. Effect of the methylenetetrahydrofolate reductase gene polymorphisms on homocysteine, folate and vitamin B12 in patients with bipolar disorder and relatives.
Ozbek Z; Kucukali CI; Ozkok E; Orhan N; Aydin M; Kilic G; Sazci A; Kara I
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1331-7. PubMed ID: 18513846
[TBL] [Abstract][Full Text] [Related]
28. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Myara A; Gerhardt M; Chevenne D; Trivin F; Farhat MB; Miled A; Maaroufi K
Ann Clin Biochem; 2006 May; 43(Pt 3):200-6. PubMed ID: 16704755
[TBL] [Abstract][Full Text] [Related]
29. Effect of TCN2 776C>G on vitamin B12 cellular availability in end-stage renal disease patients.
Födinger M; Veitl M; Skoupy S; Wojcik J; Röhrer C; Hagen W; Puttinger H; Hauser AC; Vychytil A; Sunder-Plassmann G
Kidney Int; 2003 Sep; 64(3):1095-100. PubMed ID: 12911562
[TBL] [Abstract][Full Text] [Related]
30. Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.
Toffoli G; Russo A; Innocenti F; Corona G; Tumolo S; Sartor F; Mini E; Boiocchi M
Int J Cancer; 2003 Jan; 103(3):294-9. PubMed ID: 12471611
[TBL] [Abstract][Full Text] [Related]
31. Role of folic acid depletion on homocysteine serum level in children and adolescents with epilepsy and different MTHFR C677T genotypes.
Coppola G; Ingrosso D; Operto FF; Signoriello G; Lattanzio F; Barone E; Matera S; Verrotti A
Seizure; 2012 Jun; 21(5):340-3. PubMed ID: 22425007
[TBL] [Abstract][Full Text] [Related]
32. Total homocysteine, folate, and cobalamin, and their relation to genetic polymorphisms, lifestyle and body mass index in healthy children and adolescents.
Huemer M; Vonblon K; Födinger M; Krumpholz R; Hubmann M; Ulmer H; Simma B
Pediatr Res; 2006 Dec; 60(6):764-9. PubMed ID: 17065574
[TBL] [Abstract][Full Text] [Related]
33. Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients.
Winkelmayer WC; Huber A; Wagner OF; Hörl WH; Sunder-Plassmann G; Födinger M
Kidney Int; 2005 May; 67(5):1980-5. PubMed ID: 15840047
[TBL] [Abstract][Full Text] [Related]
34. Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients.
Winkelmayer WC; Kramar R; Sunder-Plassmann G; Födinger M
Kidney Int; 2005 Dec; 68(6):2857-62. PubMed ID: 16316363
[TBL] [Abstract][Full Text] [Related]
35. Prospective study of first stroke in relation to plasma homocysteine and MTHFR 677C>T and 1298A>C genotypes and haplotypes - evidence for an association with hemorrhagic stroke.
Hultdin J; Van Guelpen B; Winkvist A; Hallmans G; Weinehall L; Stegmayr B; Nilsson TK
Clin Chem Lab Med; 2011 Sep; 49(9):1555-62. PubMed ID: 21631392
[TBL] [Abstract][Full Text] [Related]
36. Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis.
Spiroski I; Kedev S; Antov S; Arsov T; Krstevska M; Dzhekova-Stojkova S; Bosilkova G; Kostovska S; Trajkov D; Petlichkovski A; Strezova A; Efinska-Mladenovska O; Spiroski M
Acta Biochim Pol; 2008; 55(3):587-94. PubMed ID: 18800176
[TBL] [Abstract][Full Text] [Related]
37. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
38. Impact of homocysteinemia on long-term renal transplant survival.
Fonseca I; Martins L; Queirós J; Mendonça D; Dias L; Sarmento AM; Henriques AC; Cabrita A
Transplant Proc; 2005; 37(6):2784-8. PubMed ID: 16182810
[TBL] [Abstract][Full Text] [Related]
39. Hyperhomocysteinemia and methylenetetrahydrofolate reductase 677C-->T and 1298A-->C mutations in patients with inflammatory bowel disease.
Fernández-Miranda C; Martínez Prieto M; Casis Herce B; Sánchez Gómez F; Gómez González P; Martínez López J; Sáenz-López Pérez S; Gómez de la Cámara A
Rev Esp Enferm Dig; 2005 Jul; 97(7):497-504. PubMed ID: 16262529
[TBL] [Abstract][Full Text] [Related]
40. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
Adinolfi LE; Ingrosso D; Cesaro G; Cimmino A; D'Antò M; Capasso R; Zappia V; Ruggiero G
Hepatology; 2005 May; 41(5):995-1003. PubMed ID: 15834927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
